Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Internist (Berl) ; 61(1): 21-35, 2020 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-31889210

RESUMO

Dyspnea is a very common symptom leading to visits to a general physician (GP). Correct differential diagnosis is the major challenge for the GP. There are no guidelines on dyspnea. This review provides an overview of the main causal diseases for dyspnea, presents methods for history taking and differential diagnosis, and specifies the role of GPs in the primary care setting in the case of dyspnea.


Assuntos
Dispneia/diagnóstico , Atenção Primária à Saúde , Diagnóstico Diferencial , Dispneia/etiologia , Humanos
2.
Eur J Gastroenterol Hepatol ; 29(5): 503-508, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28092642

RESUMO

AIM/OBJECTIVES/BACKGROUND: Chronic hepatitis C (CHC) virus infection is a leading cause of liver-related morbidity and mortality. In Germany, as in many other countries, there is a lack of comprehensive epidemiological data. Routine data from sickness funds can support the estimation of the true prevalence and incidence of CHC. METHODS: In this article, the results of annual and quarterly analyses of prevalence and incidence for the years 2007-2013 are presented using data of several German sickness funds. RESULTS: Overall, the prevalence rate remained relatively stable at 0.2%, which is lower than the general assumption for Germany of 0.3%. CONCLUSION: We found that despite the introduction of the breakthrough designated triple therapies with telaprevir or boceprevir in 2011, there was no increase of prevalence or incidence between 2010 and 2011.


Assuntos
Antivirais/uso terapêutico , Hepatite C Crônica/epidemiologia , Adulto , Idoso , Quimioterapia Combinada , Feminino , Alemanha/epidemiologia , Hepatite C Crônica/tratamento farmacológico , Humanos , Incidência , Seguro Saúde/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Oligopeptídeos/uso terapêutico , Prevalência , Prolina/análogos & derivados , Prolina/uso terapêutico , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...